Efficacy and Safety of iStent Inject Implantation in Manual and Femtosecond Laser-assisted Cataract Surgery before Lens Extraction.

Q3 Medicine
David Kevin Manning, Ali Haider, Colin Clement, Deepa Viswanathan
{"title":"Efficacy and Safety of iStent Inject Implantation in Manual and Femtosecond Laser-assisted Cataract Surgery before Lens Extraction.","authors":"David Kevin Manning,&nbsp;Ali Haider,&nbsp;Colin Clement,&nbsp;Deepa Viswanathan","doi":"10.5005/jp-journals-10078-1374","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To describe the efficacy and safety of iStent implantation prior to phacoemulsification in manual as well as femtosecond laser-assisted cataract surgery (FLACS), and highlight this approach as a reasonable, if not necessary, step to advance one's ability and confidence in the use of microinvasive glaucoma surgery (MIGS) technology in phakic patients.</p><p><strong>Methods: </strong>A retrospective consecutive case series of patients with open angle glaucoma or ocular hypertension who underwent iStent inject implantation followed by cataract surgery (manual or FLACS). All cases underwent postoperative video review and were assessed and classified for intraoperative lens injury and hyphaema. Postoperative data included intraocular pressure (IOP), medication usage and adverse events.</p><p><strong>Results: </strong>Sixty-three eyes (<i>n</i> = 40 manual, <i>n</i> = 23 FLACS) were analyzed. Preoperatively, the mean IOP was 19.2 ± 4.9 mm Hg on 1.4 ± 0.96 mean medications, with 100% of eyes treated with medication. Intraoperatively, no lens injury was identified, and no significant hyphaema that impeded surgery occurred. At 6 months postoperative, mean IOP was 14.2 ± 1.8 mm Hg (38% reduction: <i>p</i> < 0.001), and >90% of eyes had IOP ≤ 16 mm Hg. The mean number of medications reduced to 0.11 ± 0.3 (92% reduction: <i>p</i> < 0.001), with 89% of eyes medication free. Safety was excellent for both manual and FLACS, with two iStents implanted in all eyes, and no cases of significant hyphaema or lens injury.</p><p><strong>Conclusion: </strong>Early implantation is safe, maximizes corneal clarity and angle visualization, avoids the risk of non-implantation due to surgical complications, and has a high success rate in both manual cataract surgery and the setting of FLACS.</p><p><strong>Clinical significance: </strong>The conventional recommended approach of iStent implantation following cataract extraction has been adopted by many, however, with the advent of stand-alone procedures and concern about potential lens injury, there is an opportunity to gain experience with minimal risk in patients undergoing MIGS procedures combined with cataract surgery by implanting iStents at the start of the procedure. There is currently little emphasis or data published in the literature on an early approach to implantation to guide surgeons.</p><p><strong>How to cite this article: </strong>Manning DK, Haider A, Clement C, <i>et al.</i> Efficacy and Safety of iStent Inject Implantation in Manual and Femtosecond Laser-assisted Cataract Surgery before Lens Extraction. J Curr Glaucoma Pract 2022;16(2):105-110.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"16 2","pages":"105-110"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/74/81/jocgp-16-105.PMC9452712.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Current Glaucoma Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10078-1374","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Aim: To describe the efficacy and safety of iStent implantation prior to phacoemulsification in manual as well as femtosecond laser-assisted cataract surgery (FLACS), and highlight this approach as a reasonable, if not necessary, step to advance one's ability and confidence in the use of microinvasive glaucoma surgery (MIGS) technology in phakic patients.

Methods: A retrospective consecutive case series of patients with open angle glaucoma or ocular hypertension who underwent iStent inject implantation followed by cataract surgery (manual or FLACS). All cases underwent postoperative video review and were assessed and classified for intraoperative lens injury and hyphaema. Postoperative data included intraocular pressure (IOP), medication usage and adverse events.

Results: Sixty-three eyes (n = 40 manual, n = 23 FLACS) were analyzed. Preoperatively, the mean IOP was 19.2 ± 4.9 mm Hg on 1.4 ± 0.96 mean medications, with 100% of eyes treated with medication. Intraoperatively, no lens injury was identified, and no significant hyphaema that impeded surgery occurred. At 6 months postoperative, mean IOP was 14.2 ± 1.8 mm Hg (38% reduction: p < 0.001), and >90% of eyes had IOP ≤ 16 mm Hg. The mean number of medications reduced to 0.11 ± 0.3 (92% reduction: p < 0.001), with 89% of eyes medication free. Safety was excellent for both manual and FLACS, with two iStents implanted in all eyes, and no cases of significant hyphaema or lens injury.

Conclusion: Early implantation is safe, maximizes corneal clarity and angle visualization, avoids the risk of non-implantation due to surgical complications, and has a high success rate in both manual cataract surgery and the setting of FLACS.

Clinical significance: The conventional recommended approach of iStent implantation following cataract extraction has been adopted by many, however, with the advent of stand-alone procedures and concern about potential lens injury, there is an opportunity to gain experience with minimal risk in patients undergoing MIGS procedures combined with cataract surgery by implanting iStents at the start of the procedure. There is currently little emphasis or data published in the literature on an early approach to implantation to guide surgeons.

How to cite this article: Manning DK, Haider A, Clement C, et al. Efficacy and Safety of iStent Inject Implantation in Manual and Femtosecond Laser-assisted Cataract Surgery before Lens Extraction. J Curr Glaucoma Pract 2022;16(2):105-110.

Abstract Image

Abstract Image

Abstract Image

人工和飞秒激光辅助白内障摘晶状体术前注射iStent植入术的疗效和安全性。
目的:描述人工和飞秒激光辅助白内障手术(FLACS)超声乳化前植入术的有效性和安全性,并强调这种方法是合理的,如果没有必要的话,可以提高人们在晶状体患者中使用微创青光眼手术(MIGS)技术的能力和信心。方法:回顾性分析开角型青光眼或高眼压患者行人工晶状体注射植入术后白内障手术(手工或FLACS)的连续病例系列。所有病例均接受术后录像检查,并对术中晶状体损伤和水肿进行评估和分类。术后数据包括眼压(IOP)、药物使用和不良事件。结果:分析63只眼(n = 40手动眼,n = 23 FLACS眼)。术前平均IOP为19.2±4.9 mm Hg,平均用药1.4±0.96,100%用药。术中,没有发现晶状体损伤,也没有发生阻碍手术的明显水肿。术后6个月,平均IOP为14.2±1.8 mm Hg(降低38%,p < 0.001), >90%的眼IOP≤16 mm Hg,平均用药次数减少至0.11±0.3(降低92%,p < 0.001), 89%的眼免用药。手动和FLACS的安全性都很好,在所有的眼睛中植入了两个iStents,没有明显的水肿或晶状体损伤。结论:早期植入术是安全的,可最大限度地提高角膜清晰度和角度可视性,避免因手术并发症而无法植入术的风险,无论是人工白内障手术还是FLACS的设置,都具有较高的成功率。临床意义:传统推荐的白内障摘出后人工晶体植入术已被许多人采用,然而,随着独立手术的出现和对潜在晶状体损伤的担忧,在手术开始时植入人工晶体可以使接受MIGS手术和白内障手术的患者以最小的风险获得经验。目前文献中很少强调或发表关于早期植入方法来指导外科医生的数据。如何引用本文:Manning DK, Haider A, Clement C,等。人工和飞秒激光辅助白内障摘晶状体术前注射iStent植入术的疗效和安全性。中华青光眼杂志;2010;16(2):105-110。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Current Glaucoma Practice
Journal of Current Glaucoma Practice Medicine-Ophthalmology
CiteScore
1.00
自引率
0.00%
发文量
38
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信